For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251212:nRSL4629La&default-theme=true
RNS Number : 4629L Intl. Biotechnology Trust PLC 12 December 2025
Annual General Meeting
International Biotechnology Trust plc (the "Company") announces that a poll
was held on each of the resolutions proposed at the Annual General Meeting
("AGM") on 12 December 2025. The results of the poll are:
Resolution Votes For % Votes Against % Votes Withheld Total Votes Cast (excl. Votes Withheld) % of Issued Share Capital
1 To receive the Annual Report and Financial Statements 9,807,779 88.62 1,259,469 11.38 13,267 11,067,248 34.69
2 To approve the Company's dividend policy 11,051,409 99.96 4,027 0.04 25,079 11,055,436 34.65
3 To approve the Directors' Remuneration Report 10,969,750 99.41 65,531 0.59 45,234 11,035,281 34.59
4 To elect Alexa Henderson 11,014,335 99.75 27,060 0.25 39,120 11,041,395 34.61
5 To re-elect Gillian 10,989,914 99.53 52,254 0.47 38,347 11,042,168 34.61
Elcock
6 To re-elect Kate Cornish-Bowden 11,011,634 99.72 30,534 0.28 38,347 11,042,168 34.61
7 To re-elect Patrick 11,040,180 99.88 13,800 0.12 26,535 11,053,980 34.65
Magee
8 To re-elect Patrick Maxwell 11,041,440 99.90 10,947 0.10 28,128 11,052,387 34.64
9 To appoint Johnston Carmichael LLP as Auditors 11,031,249 99.80 21,652 0.20 27,614 11,052,901 34.65
10 To authorise the Directors' determination of the remuneration of Johnston 11,034,924 99.86 15,310 0.14 30,281 11,050,234 34.64
Carmichael LLP
11 To approve the continuation of the Company 11,064,221 99.95 5,864 0.05 10,430 11,070,085 34.70
12 To renew the Directors' authority to allot shares 11,039,634 99.80 22,029 0.20 18,852 11,061,663 34.67
13* To approve the disapplication of pre-emption rights 10,957,526 99.31 76,546 0.69 46,443 11,034,072 34.59
14* To renew the authority to make market purchases of the Company's own shares 10,707,128 96.85 348,476 3.15 24,841 11,055,604 34.65
15* To approve that a general meeting, other than an annual general meeting, may 11,029,481 99.70 32,818 0.30 18,216 11,062,299 34.67
be called on not less than 14 clear days' notice
*Resolutions 13 to 15 were passed as special resolutions. Copies of
resolutions 11 to 15 will be filed at Companies House.
Shareholders are entitled to one vote per share. Votes withheld are not a vote
in law and are therefore not counted in the calculation of the percentages of
the votes cast for and against a resolution. Where shareholders appointed the
Chair as their proxy with discretion as to voting, their votes were cast in
favour of the resolutions and their shares have been included in the "votes
for" column.
The total issued share capital consists of 41,383,817 ordinary shares
of £0.25 each, which includes 9,480,983 ordinary shares held in treasury.
Treasury shares do not carry voting rights, therefore the total number voting
rights in the Company is 31,902,834.
In accordance with UKLR 6.4.2, a copy of the resolutions passed, other than
the resolutions concerning ordinary business, at today's AGM will be submitted
to the National Storage Mechanism and will be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
The proxy votes lodged with the Company's Registrar will shortly be available
via the Company's web pages at International Biotechnology Trust plc - IBT
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGFFWFWEEISELE
Copyright 2019 Regulatory News Service, all rights reserved